ABSTRACT A plasmid containing human preproinsulin cDNA inserted into the endonuclease Pst I site of the ampicillinase gene of plasmid pBR322 was modified by excision of large portions of the ampicillinase-coding region to produce a variety ofgene fusion combinations, many of which generated proteins detectable with antisera to insulin or human C peptide. In one case a perfect hybrid of the NH2-terminal half of the leader sequence of ampicillinase (residues -23 to -12) with the human preproinsulin prepeptide beginning at residue -13 was formed; the result was the synthesis and secretion of human proinsulin into the periplasmic space. We have characterized this protein immunologically and also by labeling it biosynthetically or by iodination followed by immunoprecipitation and automated amino acid sequence analysis. It contains the A and B chain regions of insulin as well as specific human C peptide immunodeterminants and is convertible to an insulin-like component by tryptic digestion. These results demonstrate that human proinsulin can be produced by bacteria and that this biosynthetic approach should prove feasible for the production of adequate amounts of human proinsulin for a variety of clinical studies and human insulin for therapeutic purposes. The development of recombinant DNA technology has led to the demonstration that bacteria can be genetically engineered to produce eukaryotic proteins, such as human insulin and interferons, for research and therapeutic purposes. In the case of insulin, Goeddel et aL (1) chemically synthesized DNA sequences encoding the A and B peptide chains and ligated these separately to the 3' end of the Escherichia coli f-galactosidase gene. The expected fusion proteins were obtained, and from them the A and B chains were released by chemical degradation (with CNBr), purified individually, and recombined to form biologically active insulin (2).
rectly cleaved to rat proinsulin and segregated into the periplasmic space. We report here that human preproinsulin containing a hybrid (prokaryotic and eukaryotic) prepeptide sequence can also be secreted and correctly processed to proinsulin in E. coli. We have characterized the secreted form by a highly sensitive technique involving iodination, immunoprecipitation, and sequence analysis on a micro scale. The results confirm the integrity of the protein and the accuracy of the cleavage process.
MATERIALS AND METHODS Plasmid Construction. Recombinant DNA was handled as prescribed by the National Institutes of Health guidelines. The parental plasmid, pHn677, was obtained by cDNA cloning of mRNA isolated from a human insulinoma and inserted into the endonuclease Pst I site ofpBR322 by oligo(dC)-oligo(dG) tailing.
pHn677 contains the coding sequence for human preproinsulin (6) minus the NH2-terminal seven amino acids of the prepeptide. To construct expression plasmids, most of the amp gene upstream from the preproinsulin sequence was removed in the following manner: (i) pHn677 was linearized with Pvu I, subjected to limited digestion with Bal 31, and cleaved with HindIII, and the large fragment was purified by agarose gel electrophoresis; (ii) pBR322 was cleaved with HincII, similarly digested with Bal 31, and cleaved with HindIII, and the DNA fragment containing the amp promoter was isolated; (iii) the two fragments were ligated with T4 DNA ligase and used to transform E. coli strain K-12 CS412; (iv) colonies were scored for expression by an in situ radioimmunoassay procedure (8) .
Preparation of Osmotic Shock Fluids. Strain K-12 CS412 (auxotrophic for vitamin B1, threonine, proline, and leucine) (9) harboring recombinant plasmids was grown exponentially in Bonner-Vogel medium (10) containing glucose and supplemented with vitamin B1, threonine, proline, leucine, and tetracycline at 4 ,ug/ml. Cultures were centrifuged, and the cells were washed twice in 10 mM Tris'HCl buffer, pH 8.0/30 mM NaCl and then resuspended in 20% sucrose/30 mM Tris HCl, pH 8.0/1 mM EDTA. After incubation at room temperature for 10 min the cells were centrifuged and resuspended in distilled H20. After 10 min at 4°C the cells were removed by centrifugation, yielding the osmotic shock fluid as a supernatant. For assay of total insulin-related peptides aliquots of cultures were disrupted with a Branson 350 sonicator for 1 min at full power. In these experiments insulin and human C peptide immunoassays were performed with commercial kits supplied by Amersham and Calbiochem/Boehringer, respectively. lodination and Immunoprecipitation. Iodination was performed by using an adaptation of the method of Freychet et aL (11) . Protein samples (3-5 ,ug) were dissolved in 20 ,ul of 0.3 M sodium phosphate buffer, pH 7.4 followed by 7 Al of 0.2 M monobasic sodium phosphate and 5-10 ,ul (2.5-3.0 mCi; 1 Ci = 3.7 X 1010 becquerels) of carrier-free Na125I in water. The reaction was initiated by adding 15 ,ul of chloramine T (30 ,ug/ ml). The samples were allowed to stand several hours in a hood and were then diluted to 0.5 ml with TAS buffer (0.1 M Al~breviation: TAS buffer, Tris/albumin/sodium chloride buffer.
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Tris HCl, pH 7.8/0.05 M NaCV2.5 mg of bovine serum albumin per ml). To reduce nonspecific reactions, 3 tkl of normal guinea pig serum was added and the samples were incubated for 30 min at room temperature. Then 75 jAd ofa 10% suspension of formalin-fixed heat-killed Staphylococcus aureus (Cowan I strain) (Miles Laboratories) was added and after 30 min at 20C the bacteria were removed by centrifugation. The supernatants were brought to 0.5% with Triton X-100, 3 ,ul ofguinea pig antiinsulin serum was added, and the tubes were incubated 30 min at room temperature and then overnight at 40C. Immune complexes were collected as above by addition of 75 Al of 10% S.
aureus suspension followed by centrifugation and were either eluted with 50% (vol/vol) acetic acid or taken up in 100 A.l of urea-containing buffer for reduction and carboxymethylation (see below). Reduction and Carboxymethylation. For this procedure we used the method of Crestfield et aL (12) , except dithiothreitol was substituted for 2-mercaptoethanol. After the coupling reaction was complete the protein and S. aureus mixture was precipitated by the addition of5 vol ofcold 20% trichloroacetic acid. After centrifugation the pellet was washed once with absolute ethanol, partially dried, and dissolved in 50% acetic acid. The S. aureus cells were removed by centrifugation and the supernatant solution was stored at -18°C.
RESULTS
Description of the Plasmids and Preliminary Analyses of Their Secretory Products. We initially inserted human preproinsulin cDNA, constructed from an insulinoma mRNA, into the Pst I site of pBR322 located within the ampicillinase gene (7) . DNA sequence analysis of pHn677 determined that the preproinsulin cDNA was transcribed in the same direction as the ampicillinase gene but in a different reading frame. In order to achieve expression and to remove most of the ampicillinase coding sequence, we treated pHn677 with limited nuclease digestion as described in Materials and Methods. A number of recombinants were obtained that produced material reactive with anti-insulin or anti-C-peptide sera or both, and two of these, pJW1272 and pJW1452, were selected for further study. It was found that in both cases, the insulin and C peptide immunodeterminants were secreted into the periplasmic space (Table 1 ). Fig. 1 shows the distribution of both forms of immunoreactivity on gel filtration of the osmotic shock fluids prepared from small bacterial cultures. In the case of plasmid pJW1452 the major immunoreactive component was larger than proinsulin ( Fig. 1A) , with a molecular mass ofabout 15,000 daltons. A smaller peak of immunoreactive material similar in size to proinsulin was also detected (Fig. 1A) . Treatment with trypsin generated a component having the exclusion characteristics of the free human C peptide, while the insulin immunoreactivity created a broad smear, suggesting that additional amino acid sequences might be attached to the NH2 terminus of the B chain (data not shown). These results suggested that plasmid pJW1452 generates a fusion protein containing 40-50 amino acids in addition to human proinsulin, as well as small amounts of a proinsulin-like component.
In contrast, gel filtration of the concentrated osmotic shock fluid from cultures of bacteria containing plasmid pJW2172 (Fig. 1B ) gave rise to a single homogeneous peak of C peptide and insulin immunoreactivity that coeluted at the position of the proinsulin standard. Moreover, the ratio of C peptide to insulin immunoreactivity of this component (approximately 1:15) corresponded well to the known crossreactivity ofhuman proinsulin in the highly specific human C peptide immunoassay currently in use in our laboratories (14) , while this was not the case with the larger fusion product derived from plasmid pJW1452, which was less reactive (about 1A normal) with insulin antisera (data not shown).
These findings are readily explained by DNA sequence analyses ofthe fused regions ofboth plasmids. In pJW1452 the coding sequence indicated that the junction was between residue 65 of the ampicillinase sequence and residue -13 of the prepeptide region ofhuman preproinsulin (Fig. 2) . This particular arrangement would generate a fusion protein containing the complete ampicillinase prepeptide sequence followed by 42 residues of the mature ampicillinase protein and then by the sequence of human preproinsulin extending from residue -13 in the prepeptide to the normal termination site at the COOHterminus of the A chain. Cleavage after the ampicillinase prepeptide sequence during secretion would generate a 14,600-dalton protein corresponding to the major immunoreactive peak seen in Fig. 1A . The size ofthis protein also has been confirmed by filter affinity transfer after NaDodSO4 gel electrophoresis of the osmotic shock fluid (data not shown).
DNA sequence analysis ofplasmid pJW2172 (Fig. 2) revealed that fusion had occurred between residue L12 of the ampicillinase leader peptide sequence (7) and residue -14 of the human prepeptide sequence, creating a perfect hybrid leader se- Predicted amino acid sequences in the NH2-terminal regions of ampicillinase fusion proteins coded by plasmids pJW1452 and pJW2172 derived from DNA sequence analysis (16) . The underlined portions of the sequences are from the ampicillinase and are numbered according to Sutcliffe (7) . The preproinsulin sequence is numbered from the cleavage site (arrow) for maturation to proinsulin. The DNA sequence in thejunctional region is shown below each amino acid sequence.
quence containing roughly halfofeach presequence without any substitutions or modifications. This fused leader sequence preserves all of the structural features believed to be required for export and cleavage (17) and would be expected to generate a correctly cleaved secreted product. The experiments that follow demonstrate that this is the case.
Characterization of the pJW2172 Secreted Product. In order to further characterize the proinsulin-like material generated by plasmid pJW2172, a sample of the osmotic shock fluid containing about 0.05 nmol of the peptide was extracted with acid/ethanol and.the extract was then chromatographed on a column of Bio-Gel P60 eluted with 2.5 M propionic acid (18) . The fraction containing-the peak insulin immunoreactivity (approximately 0.01 nmol) was dried under reduced pressure and divided into two equal aliquots, one of which was labeled by iodination and then immunoprecipitated with insulin antiserum. The resultant immunoprecipitate (containing 2.7 X 106 cpm), when examined on a Bio-Gel P30 column eluted with 3 M acetic acid, gave a single peak at the position of proinsulin, and on tube gel NaDodSO4 electrophoresis it migrated as a single component with the same mobility as a bovine proinsulin standard (Fig. 3) .
To determine whether cleavage of the presequence had occurred at .the first residue ofhuman proinsulin, a portion of the above immunoprecipitate (0.5 pmol), after reduction and carboxymethylation, was subjected to automated Edman degradation. The results are shown in Fig. 4A . Significant amounts of labeled tyrosine were found only at positions 16 and 26, as expected for human proinsulin. There was no indication of heterogeneity at the NH2 terminus. Further corroboration on this pointwas obtained when the protein in the osmotic shock fluid from a culture grown in the presence of3SO4 was similarly immunoprecipitated, gel filtered, reduced, carboxymethylated, and then sequenced. The results shown in Fig. 5 units; 7.5 mCi of 36S was added to each medium and about 50% was incorporated. Osmotic shock fluids were prepared as described above and aliquots were used for immunoprecipitation studies. Immunoprecipitation was carried out on the unfractionated osmotic shock fluid and the products were reduced, carboxymethylated, and further purified by gel filtration. The radioactivities of the products from each cycle of degradation, dissolved in 3 ml of butyl chloride plus 10 ml of Aquasol (New England Nuclear), were measured in a liquid scintillation counter.
Edman degradation. The results shown in Fig. 4B demonstrate unequivocally that the protein contained the normal A chain, having tyrosines at positions 14 and 19, and that trypsin had also cleaved the B chain region at residue 22 (arginine) to generate a heptapeptide (19) which now contained the B26 tryosine residue at position 4. Second, the presence of C peptide immunodeterminants in this material (which had originally been obtained by immunoprecipitation with an insulin antiserum) was assesed by binding to an antiserum against, human C peptide. The results shown in Fig. 6 demonstrate that the carboxymethylated bacterial protein reacted as well as authentic iodinated human C peptide, whereas porcine proinsulin did not bind significantly to the antiserum. Finally, we found that, when treated with trypsin and carboxypeptidase B (4), the pJW2172 proinsulin was converted to a component eluting at the position of insulin on gel filtration (data not shown). There was no indication of the release offree A or B chain material. On the basis of all the above evidence it is clear that the product generated by pJW2172 is intact human proinsulin;
DISCUSSION
The results presented here extend and amplify observations made previously by Talmadge et aL (5) , who studied several ampicillinase-rat preproinsulin hybrid preprotein sequences. In their plasmids the fusions involved portions ofboth the ampicillinase and the preproinsulin leader sequences, usually connected by short interposed sequences derived from the construction process and unrelated to either presequence. two plasmids we have studied here the method of construction has produced fused proteins that are not substituted or modified.
In the case of plasmid pJW1452 half of the human presequence has been fused to a 65-residue NH2-terminal coding segment of the preampicillinase gene (7) . The product of this plasmid appears to be cleaved predominantly after the ampicillinase leader sequence to generate a 14,600-dalton fused protein, although we also found a small amount of proinsulin-like material on gel filtration. The corresponding plasmid of this type constructed by Talmadge et aL (5) contained only a short intervening segment of foreign peptide material between the two presequences, and its product was processed correctly after the rat presequence; whether it was also processed after the ampicillinase presequence was not reported.
A possible explanation for a low cleavage rate in the modified preproinsulin leader. sequence in plasmid pJW1452 may be the relocation of a proline residue from its normal location at position -16 in the human prepeptide to position -14, as well as other more polar substitutions upstream (Fig. -2) , thus possibly reducing-the length ofa potential non-polar (3-sheet structuret that can be formedwithin the cell membrane by the central hydrophobic core of this prepeptide-like region (17 In plasmid pJW2172 the prepeptides of both proteins were joined in a hybrid structure consisting of almost equal halves of each presequence. In this hybrid presequence the proline residue normally at position -16 also is shifted to position -14. The protein produced by this plasmid is intact human proin-*sulin. However, the yield ofinsulinlike immunoreactivity from this plasmid is approximately 0. 1-0.2 that produced by plasmid pJW1452 (Table 1 ). Whether this difference truly reflects a reduced efficiency of the hybrid prepeptide in export or is due to other factors such as differences in the stability ofproinsulin versus* the fusion protein within the periplasmic space, is not yet known. The only evidence in the literature bearing indirectly on this point comes from' work of Bedouelle et aL (20) on fusions or mutations within the leader sequence ofthe maltosebinding protein that alter its secretion. Both a hybrid protein (PB4-81) and a~point mutation, (10-1) resulted in-the appearance ofa proline residue within,the hydrophobic~segment ofthe presequence. In the case of PB4-81 the defect in export cannot be ascribed solely to' the intrusion ofproline because 12 additional residues in the downstream portion ofthe prepeptide were.also altered.' However, in point mutant 10-1 the replacement ofleucine by proline significantly reduced the export of the-maltosebinding protein. It should be noted,.however, that the normal ampicillinase leader sequence contains a proline residue at position -12. Whether its presence affects the relative efficiency ofexport ofampicillinase under.normal conditions of expression is not known. t Clearly, much further work will be required to clarify the rules for,recognition and function ofsignal sequences.
Nonetheless, our results clearly underscore the relative functional universality of the presequences of prokaryotes and eukaryotes.
The method we have' used for the.characterization of human proinsulin in these experiments may have wider application for other proteins and peptides containing tyrosine residues in view of its ease and great sensitivity. Thus by the simple expedient of iodination with carrier-free Na'"I followed by immunoprecipitation we were able to detect and characterize amounts of protein. in the range of a few picomoles. Using this technique, we were able to demonstrate that the human proinsulin generated by E. coli containing pJW2172 was (i) correctly-cleaved from preproinsulin by the bacteria, (ii) contained normal A and .B chain segments, (iii) contained specific human C peptide immunodeterminants, (iv) contained disulfide bridges, and (v) could be converted to insulin-like material by digestion with trypsin and carboxypeptidase B.
Because of the species specificity and the immunogenicity of animal proinsulins in man, it has hitherto been impossible to study the possible role of proinsulin in normal physiology in .man. Previous studies have demonstrated that the normal' human pancreas secretes about 5% proinsulin and intermediate cleavage products along with insulin, and that, due to its slower disappearance rate, proinsulin constitutes up to 50% of the insulin-like material in the blood in the basal state (21) . With the advent of these methods of bacterially assisted synthesis it should soon be possible to produce sufficient quantities of human proinsulin to begin to.investigate its normal role in metabolic regulation and its possible application in the therapy of insulin-dependent'forms of diabetes.
